OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
OmniComm Systems and Bio-Optromics have reached an agreement with a CRO seeking to develop cancer treatments, for the use of their EDC and CTMS solutions.
OmniComm Systems and Bio-Optromics have reached an agreement with a CRO seeking to develop cancer treatments, for the use of their EDC and CTMS solutions.
Read the full release here